miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow.

Tong ChenZhen-Yu WangChuan-Chang Li

Published in: Cardiology research and practice (2020)

The expression of serum miRNA-22 in CSF is upregulated compared to that in subjects with normal coronary flow and shows relatively high clinical diagnostic efficiency, suggesting a new potential biomarker for the early diagnosis of CSF.

Keyphrases

coronary artery disease
coronary artery
poor prognosis
aortic stenosis
cerebrospinal fluid
binding protein
long non coding rna
atrial fibrillation
transcatheter aortic valve replacement